# FDA Inspection 932111 - Biomat USA Inc - June 23, 2015

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7dcbf5c0-3c5e-4735-94de-09a1bcb418b6
Source feed: FDA_Inspections

> FDA Inspection 932111 for Biomat USA Inc on June 23, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 932111
- Company Name: Biomat USA Inc
- Inspection Date: 2015-06-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1119012 - 2020-01-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/51286912-2d5e-45b2-9cd6-553bd385b116)
- [FDA Inspection 1002180 - 2017-02-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/efe94001-9bca-4ee1-8c75-6f1d81e7d7cb)
- [FDA Inspection 774866 - 2012-03-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a21dae84-f3d5-4e74-a3d9-2d8e26b518f7)
- [FDA Inspection 651287 - 2010-03-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5bb7b0ac-19f0-4817-8506-1ae50fc327ce)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8b448875-36c4-489c-97ba-e98255edfb28

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d